CHM.AX · CHIMERIC THERAPEUTICS LIMITED
Australia · RS rating 1 · As of 2026-10-14
| Price | 0.00 AUD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 1 / 1 / 1 / 1 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 15 / 15 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +99.2% |
| Market cap (USD) | $307,831 |